YOLFTbeta
Femasys Inc

Femasys Inc

FEMY · NASDAQ · Healthcare / Medical Instruments & Supplies

1.42USD+0.02 (+1.43%)

Price History

Full chart

Market Stats

Previous Close1.40
Open1.46
Day Range1.40 – 1.54
52-Week Range2.02 – 22.20
Volume52.89K
Market Cap20.35M
P/E (TTM)0.00
Forward P/E0.00
EPS-2.60
Dividend Yield0.00%
Beta-2.07
50-Day Avg2.85
200-Day Avg7.76

About

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Kathy Lee-Sepsick M.B.A.
  • Employees51
  • Headquarters3950 Johns Creek Court, Suwanee, GA, United States, 30024, USA
  • Websitehttps://femasys.com

Leadership

  • Ms. Kathy Lee-Sepsick M.B.A.Founder, President, CEO & Director · b. 1968
  • Mr. Dov ElefantChief Financial Officer · b. 1967
  • Mr. John CanningChief Operating Officer · b. 1974
  • Dr. James H. Liu M.D.Chief Medical Officer

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue929.06K1.04M1.18M1.21M1.07M1.63M2.29M
Growth (%)-+11.72%+13.66%+2.25%-11.13%+51.97%+40.77%
Cost of Revenue223.68K306.53K370.38K441.94K380.07K544.90K872.40K
Gross Profit705.39K731.38K809.30K764.28K691.90K1.08M1.42M
Gross Margin75.92%70.47%68.60%63.36%64.54%66.55%61.96%
Operating Expense12.34M7.66M9.15M12.36M15.20M18.87M19.01M
Operating Income-11.64M-6.93M-8.34M-11.60M-14.51M-17.79M-17.59M
Operating Margin-1252.57%-667.99%-706.70%-961.71%-1353.43%-1091.75%-766.95%
EBITDA-10.16M-5.80M-6.55M-10.49M-13.17M-16.33M-15.89M
EBITDA Margin-1094.04%-558.80%-555.26%-869.27%-1228.52%-1002.48%-692.67%
Net Income-11.27M-6.91M-7.54M-11.39M-14.25M-18.82M-18.63M
Net Income Margin-1213.26%-666.24%-638.97%-944.62%-1329.06%-1155.03%-812.27%
R&D6.91M4.13M4.08M5.81M7.21M8.22M7.58M
R&D as % of Total Revenue744.21%397.97%346.22%481.98%672.47%504.36%330.43%
Interest Expense9.97K12.55K19.23K13.46K165.39K1.60M1.89M
Interest Expense % of Total Revenue1.07%1.21%1.63%1.12%15.43%98.43%82.46%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.65M7.61M28.58M16.90M27.76M12.45M20.72M
Total Liabilities58.02M4.08M2.24M1.65M9.40M10.14M14.85M
Total Equity-45.37M3.53M26.33M15.24M18.35M2.30M5.87M
Cash6.42M3.32M24.78M12.96M21.72M3.45M9.27M
Total Debt1.71M2.06M990.21K543.72K6.70M7.44M4.70M
Net Debt-4.70M-1.27M-23.79M-12.42M-15.02M3.99M-4.57M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-11.01M-4.93M-7.93M-10.73M-11.28M-19.44M-18.69M
Investing Cash Flow12.32M968.32K-306.87K-407.48K-143.92K-847.76K-630.10K
Financing Cash Flow-127.78K871.65K29.70M-681.64K20.18M2.03M25.14M
Capital Expenditure696.50K31.68K306.87K407.48K143.92K761.71K525.01K
Free Cash Flow-11.70M-4.96M-8.24M-11.14M-11.42M-20.21M-19.22M
FCF to OCF106.33%100.64%103.87%103.80%101.28%103.92%102.81%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Mar 17, 2021Jun 21, 2021Aug 11, 2021Nov 10, 2021Mar 24, 2022May 11, 2022Aug 10, 2022Nov 10, 2022Mar 30, 2023May 11, 2023Aug 10, 2023Nov 14, 2023Mar 28, 2024May 9, 2024Aug 8, 2024Nov 12, 2024Mar 27, 2025May 8, 2025Aug 8, 2025Nov 14, 2025Dec 31, 2025May 8, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate0.000.000.000.000.00-0.25-0.15-0.25-4.20-5.20-4.60-5.20-0.26-4.40-5.00-0.21-4.10-3.47-3.93-3.80-0.19-3.60-2.60-1.80-1.80-1.40-
EPS Actual-2.30-1.55-1.64-0.80-0.26-0.52-0.19-0.08-4.80-4.40-5.00-4.80-0.25-4.40-5.20-0.19-3.40-4.20-4.80-4.60-0.23-3.20-2.00-0.20-1.46-1.33-
Surprise------108.00%-26.67%68.00%-14.29%15.38%-8.70%7.69%3.85%0.00%-4.00%9.52%17.07%-21.04%-22.14%-21.05%-21.05%11.11%23.08%88.89%18.89%5.00%-
Timing----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-After-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap20.35M
Enterprise Value24.62M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.85
Price / Book5.28
EPS-2.60
Book Value1.33
Revenue (TTM)2.30M
Gross Profit (TTM)1.40M
EBITDA-17.23M
Profit Margin0.00%
Operating Margin-1526.66%
Return on Equity-424.97%
Return on Assets-84.23%
Shares Outstanding8.38M
Shares Float7.35M
Beta-2.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 14.33
  • Strong Buy
    2
  • Buy
    2

Ownership Breakdown

Institutions
47.26%
Insiders
3.92%
Retail / Other
48.82%

Top Institutional Holders

  • Dauntless Investment Group, LLC
    6.03M3.60%
  • Vanguard Capital Management, LLC
    1.24M0.74%
  • Geode Capital Management, LLC
    621.37K0.37%
  • Citadel Advisors Llc
    16.92K0.20%
  • Vanguard Fiduciary Trust Co
    249.88K0.15%
  • BlackRock Inc
    178.50K0.11%
  • Northern Trust Corp
    118.41K0.07%
  • EP Wealth Advisors, Inc.
    100.00K0.06%
  • XTX Topco Ltd
    94.14K0.06%
  • State Street Corp
    80.87K0.05%
  • Virtu Financial LLC
    80.15K0.05%
  • UBS Group AG
    61.93K0.04%
  • Cetera Investment Advisers
    62.00K0.04%
  • Advisor Group Holdings, Inc.
    47.96K0.03%
  • Jane Street Group LLC
    32.28K0.02%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    34.30K0.41%
  • Fidelity Extended Market Index
    15.06K0.18%
  • Fidelity Nasdaq Composite Index
    3.94K0.05%
  • Fidelity Series Total Market Index
    3.83K0.05%
  • Fidelity Total Market Index
    2.53K0.03%

Stock Splits

  • Jun 8, 20261:20